GDF11 and early-onset autosomal dominant Alzheimer disease: Administration of GDF11 reduced cognitive deficits and amyloid deposition in a mouse model of Alzheimer’s disease [15] and resulted in vascular remodeling and neurogenesis in older wild-type mice [12].